Abstract
The effects of dietary lithium on several indices of dopamine receptor supersensitivity were examined in rats during withdrawal from chronic administration of haloperidol. Chronic haloperidol enhanced the locomotor stimulant action of d-amphetamine, and this effect was attenuated by lithium. In contrast, lithium did not affect the amphetamine response in animals that had not previously received haloperidol. Apomorphine-induced hypothermia was not influenced by the chronic haloperidol treatment. On the other hand, during withdrawal from chronic haloperidol, spontaneous locomotor activity (20 h) and apomorphine-induced stereotypy were increased, but neither of these effects was attenuated by lithium. In addition, lithium did not affect the chronic haloperidol-induced increase in 3H-spiperone binding sites in the striatum. Lithium alone had no effect on any of these measures except for causing a slight prolongation of the hypothermic effect of apomorphine. The results indicate that not all DA-receptor-mediated responses are enhanced by chronic administration of neuroleptics (e. g., apomorphine-induced hypothermia). In addition, while lithium reduces the effects of chronic haloperidol administration on d-amphetamine-induced locomotor activity, this is not because lithium prevents haloperidol-induced supersensitivity of postsynaptic DA receptors because more direct measures of this phenomenon (e.g., 3H-spiperone binding, apomorphine-induced stereotypy) are not affected by lithium.
Similar content being viewed by others
References
Banay-Schwartz M, Wadja IJ, Manigault I, DeGuzman T, Lajtha A (1982) Lithium: effect on H3H]-spiperone binding, ionic content, and amino acid levels in the brain of rats. Neurochem Res 7:179–189
Bunney WE Jr, Garland BL (1982) A second generation catecholamine hypothesis. Pharmacopsychiatria 15:111–115
Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs; chronic treatment elevates dopamine receptor binding in brain. Science 196:326–328
Clow A, Jenner P, Marsden CD (1979) Changes in dopamine-mediated behavior during one year's neuroleptic administration. Eur J Pharmacol 57:365–375
Clow A, Theodorou A, Jenner P, Marsden CD (1980) Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration. Eur J Pharmacol 63:145–157
Cooper TB, Gershon S, Kline NS, Schou M (1978) Lithium —Controversies and unresolved issues. Exerpta Medica, Amsterdam
Cox B, Lee TF (1977) Do dopamine receptors have a physiological role in thermoregulation? Br J Pharmacol 61:83–86
Cox B, Kerwin R, Lee TF (1978) Dopamine receptors on the central thermoregulatory pathways of the rat. J Physiol (Lond) 282:471–483
Creese I, Iversen SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419–436
Delanoy RL, Dunn AJ (1982) Effects of haloperidol and apomorphine on catecholamine metabolism in brain slices. Biochem Pharmacol 31:3297–3305
Dewey KJ, Fibiger HC (1983) The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity. Naunyn-Schmiedeberg's Arch Pharmacol 322:261–270
Dyer RG, Murugaiah K, Theodorou A, Clow A, Jenner P, Marsden CD (1980) During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated. Life Sci 28:167–174
Ebstein RP, Eliasher S, Belmaker RH, Ben-Uriah Y, Yehuda S (1980) Chronic lithium treatment and dopamine mediated behavior. Biol Psychiatry 15:459–467
Feltz P, DeChamplain J (1972) Enhanced sensitivity of caudate neurons to microiontophoretic injections of dopamine in 6-hydroxydopamine-treated cats. Brain Res 43:601–605
Friend WC, Brown GM, Jawahir G, Lee T, Seeman P (1978) Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum. Am J Psychiatry 135:839–841
Gallagher DW, Pert A, Bunney Jr WE (1978) Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium. Nature 273:309–312
Jus A, Villeneuve A, Gautier G, Jus K, Villeneuve C, Pires P, Villeneuve R (1978) Deanol, lithium and placebo in the treatment of tardive dyskinesia. Neuropsychobiology 4:140–149
Klawans HL, Weiner WJ, Nausieda PA (1977) The effect of lithium on an animal model of tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry 1:53–60
Lai H, Kasi Md S, Carine MA, Horita A (1982) Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat. Life Sci 30:821–826
Lapin IP, Samsonova ML (1968) Apomorphine induced hypothermia. Eur J Pharmacol 23:82–89
Leysen JE, Gommeren W, Laduron PM (1978) Spiperone: A ligand of choice for neuroleptic receptors. I. Kinetics and characteristics of in vitro binding. Biochem Pharmacol 27:307–316
Leysen JE, Gommeren W, Laduron PM (1979) Distinction between dopaminergic and serotoninergic components of neuroleptic binding sites in limbic brain areas. Biochem Pharmacol 28:447–448
Lin MT, Chern YF, Wang Z, Wang HS (1979) Effects of apomorphine on thermoregulatory responses of rats to different ambient temperatures. Can J Physiol Pharmacol 57:469–475
List SI, Seeman P (1981) Resolution of the dopamine and serotonin receptors components of [3H]-spiperone binding to rat brain regions. Proc Natl Acad Sci USA 78:2620–2624
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Martin JR, Quock RM (1979) Stabilization of apomorphine induced hypothermia in the Okamoto-Aoki spontaneously hypertensive rat by chronic lithium treatment. Proc West Pharmacol Soc 22:143–144
Meller E, Friedman E (1981) Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced DOPAC increase in rat striatum. Eur J Pharmacol 76:25–29
Meller E, Bohmaker K, Rosengarten H, Friedhoff AJ (1982) Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex. Res Commun Chem Pathol Pharmacol 37:323–332
Muller P, Seeman P (1978) Effect of long-term neuroleptic treatment on neurotransmitter receptors: relation to tardive dyskinesia. In: Smith RC, Fan WE, Davis JM, Domino EF (eds) Tardive dyskinesia: research and treatment. Spectrum, New York, pp 405–410
Pert A, Rosenblatt JE, Sivit C, Pert CB, Bunney WE Jr (1978) Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 201:171–173
Prien RF (1978) Clinical uses of lithium, part 1: Introduction. In: Cooper TB, Gershon S, Kline NS, Schou M (eds) Lithium —controversies and unresolved issues. Exerpta Medica, Amsterdam, pp 3–19
Quock RM, Carino MA, Horita A (1975) Thermotropic activity of apomorphine in the rabbit: a central site of action. Life Sci 16:523–532
Reches A, Wagner HR, Jackson V, Fahn S (1982) Chronic lithium administration has no effect on haloperidol induced supersensitivity of pre-and post-synaptic dopamine receptors in rat brain. Brain Res 246:172–177
Rosenblatt JE, Pert A, Layton B, Bunney WE Jr (1980) Chronic lithium reduces [3H]-spiroperidol binding in rat striatum. Eur J Pharmacol 67:321–322
Schelkunov EL (1967) Adrenergic effect of chronic administration of neuroleptics. Nature 214:1210–1213
Schou M (1977) The range of clinical uses of lithium. In: Johnson FN, Johnson S (eds) Lithium in medical practice. MTP Press Ltd, Lancaster, pp 21–39
Schwartz G (1982) A rational ordering of the actions of antipsychotic drugs. J Fam Prac 14:263–267
Smith D, Smith HB (1973) The effect of prolonged lithium administration on activity, reactivity, and endurance in the rat. Psychopharmacology 30:83–88
Staunton DA, Magistretti PJ, Schoemaker WJ, Bloom FE (1982a) Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity. Brain Res 232:391–400
Staunton DA, Magistretti PJ, Shoemaker WJ, Dego SN, Bloom FE (1982b) Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum: No effect on denervation or neuroleptic-induced supersensitivity. Brain Res 232:401–412
Verimer T, Goodale DB, Long JP, Flynn JR (1980) Lithium effects on haloperidol-induced pre- and postsynaptic dopamine receptor supersensitivity. J Pharm Pharmacol 32:665–666
Waddington JL, Gamble SJ (1980) Spontaneous activity and apomorphine stereotypy during and after withdrawal from −31/2 months continuous administration of haloperidol: some methodological issues. Psychopharmacology 71:75–77
Wadja IJ, Banay-Schwartz M, Mannigault I, Lajtha A (1981) Effect of lithium and sodium ions on opiate- and dopamine-receptor binding. Neurochem Res 6:321–330
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pittman, K.J., Jakubovic, A. & Fibiger, H.C. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat. Psychopharmacology 82, 371–377 (1984). https://doi.org/10.1007/BF00427688
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427688